Short Interest Coverage: Taro Pharmaceutical Industries L (NYSE:TARO) Stock Is Shorted More

November 17, 2016 - By Dolores Ford   ·   0 Comments

Short Interest Coverage: Taro Pharmaceutical Industries L (NYSE:TARO) Stock Is Shorted More

The stock of Taro Pharmaceutical Industries L (NYSE:TARO) registered an increase of 16.73% in short interest. TARO’s total short interest was 2.92 million shares in November as published by FINRA. Its up 16.73% from 2.50 million shares, reported previously. With 242,500 shares average volume, it will take short sellers 12 days to cover their TARO’s short positions. The short interest to Taro Pharmaceutical Industries L’s float is 22.22%. The stock closed at $101.59 during the last session. It is down 29.94% since April 15, 2016 and is downtrending. It has underperformed by 34.57% the S&P500.

Taro Pharmaceutical Industries Ltd. is a science pharmaceutical company. The company has a market cap of $4.19 billion. The Firm operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. It has a 8.04 P/E ratio. The Firm markets over 200 pharmaceutical products in over 25 countries.

TARO Company Profile

Taro Pharmaceutical Industries Ltd. (Taro), incorporated on June 3, 1959, is a science pharmaceutical company. The Firm develops, makes and markets prescription (Rx) and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. Taro also develops and makes active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company’s primary areas of focus include semi-solids formulations, such as creams and ointments, and other dosage forms, such as liquids, capsules and tablets, primarily in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories.

More notable recent Taro Pharmaceutical Industries Ltd. (NYSE:TARO) news were published by: Prnewswire.com which released: “Shareholder Class Action Filed Against Taro Pharmaceutical Industries Ltd. – TARO” on November 15, 2016, also Nasdaq.com with their article: “Taro Pharmaceutical Industries Enters Oversold Territory (TARO)” published on November 03, 2016, Prnewswire.com published: “EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against …” on October 25, 2016. More interesting news about Taro Pharmaceutical Industries Ltd. (NYSE:TARO) were released by: Globenewswire.com and their article: “SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of …” published on November 16, 2016 as well as Globenewswire.com‘s news article titled: “INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Taro …” with publication date: November 14, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>